Western Pacific Wealth Management, LP Gilead Sciences, Inc. Transaction History
Western Pacific Wealth Management, LP
- $137 Million
- Q1 2024
A detailed history of Western Pacific Wealth Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Western Pacific Wealth Management, LP holds 1,002 shares of GILD stock, worth $66,823. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,002
Previous 1,022
1.96%
Holding current value
$66,823
Previous $82,000
10.98%
% of portfolio
0.05%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
1,885Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.17 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.65 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.64 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.08 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.85 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $83.6B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...